EAM
Erste Asset Management Portfolio holdings
AUM
$11.9B
1-Year Return
22.95%
This Quarter Return
-1.78%
1 Year Return
+22.95%
3 Year Return
+112.82%
5 Year Return
+205.55%
10 Year Return
–
AUM
$7.79B
AUM Growth
-$363M
(-4.5%)
Cap. Flow
+$111M
Cap. Flow
% of AUM
1.43%
Top 10 Holdings %
Top 10 Hldgs %
26.25%
Holding
934
New
33
Increased
159
Reduced
182
Closed
39
Top Buys
| 1 |
TJX Companies
TJX
|
+$71.6M |
| 2 |
iShares Gold Trust
IAU
|
+$68.6M |
| 3 |
Philip Morris
PM
|
+$60.4M |
| 4 |
Booking.com
BKNG
|
+$54.8M |
| 5 |
Flowserve
FLS
|
+$44.5M |
Top Sells
| 1 |
Costco
COST
|
+$69.8M |
| 2 |
AutoZone
AZO
|
+$42.7M |
| 3 |
Starbucks
SBUX
|
+$42.5M |
| 4 |
Texas Roadhouse
TXRH
|
+$36.1M |
| 5 |
Morgan Stanley
MS
|
+$21.1M |
Sector Composition
| 1 | Technology | 32.54% |
| 2 | Healthcare | 15.82% |
| 3 | Financials | 13.77% |
| 4 | Consumer Discretionary | 9.89% |
| 5 | Communication Services | 9.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
376
Primerica
PRI
$8.71B
| $992K | 0.01% |
3,500
| – | – |
|
377
Amicus Therapeutics
FOLD
$2.48B
| $985K | 0.01% |
116,850
| – | – |
|
378
Micron Technology
MU
$158B
| $981K | 0.01% |
11,097
-112,479
| -91% | -$9.95M |
|
379
Immunovant
IMVT
$2.89B
| $964K | 0.01% |
52,500
| – | – |
|
380
Apogee Therapeutics
APGE
$2.25B
| $953K | 0.01% |
24,000
| – | – |
|
381
Credicorp
BAP
$21B
| $941K | 0.01% |
5,000
| – | – |
|
382
CVS Health
CVS
$92.7B
| $938K | 0.01% |
13,978
-2,714
| -16% | -$182K |
|
383
Steel Dynamics
STLD
$19.4B
| $927K | 0.01% |
7,450
+4,250
| +133% | +$529K |
|
|
DCBO
384
Docebo
DCBO
$874M
| $887K | 0.01% |
30,400
| – | – |
|
|
BERY
385
DELISTED
Berry Global Group, Inc.
BERY
| $875K | 0.01% |
12,600
+5,600
| +80% | +$389K |
|
386
Passage Bio
PASG
$22M
| $869K | 0.01% |
122,790
| – | – |
|
387
3M
MMM
$81.4B
| $860K | 0.01% |
5,940
-1,134
| -16% | -$164K |
|
388
CDW
CDW
$22.1B
| $857K | 0.01% |
5,310
-475
| -8% | -$76.7K |
|
389
Nuvalent
NUVL
$5.65B
| $840K | 0.01% |
11,500
| – | – |
|
390
CSX Corp
CSX
$59.5B
| $839K | 0.01% |
28,824
+4,823
| +20% | +$140K |
|
391
Elevance Health
ELV
$69B
| $830K | 0.01% |
1,920
-338
| -15% | -$146K |
|
392
Moody's
MCO
$91.1B
| $821K | 0.01% |
1,780
-392
| -18% | -$181K |
|
393
Sociedad Química y Minera de Chile
SQM
$12B
| $805K | 0.01% |
20,000
| – | – |
|
394
CubeSmart
CUBE
$9.3B
| $803K | 0.01% |
19,100
-1,300
| -6% | -$54.7K |
|
395
Kymera Therapeutics
KYMR
$3.09B
| $800K | 0.01% |
27,000
| – | – |
|
396
Corteva
CTVA
$49B
| $794K | 0.01% |
13,000
| – | – |
|
397
Janux Therapeutics
JANX
$1.45B
| $786K | 0.01% |
+27,000
| New | +$786K |
|
398
Banco Macro
BMA
$2.98B
| $784K | 0.01% |
10,000
| – | – |
|
399
Phillips 66
PSX
$52.1B
| $779K | 0.01% |
+6,400
| New | +$779K |
|
400
Progyny
PGNY
$1.95B
| $778K | 0.01% |
35,528
| – | – |
|